Senataxin deficiency disrupts proteostasis through nucleolar ncRNA-driven protein aggregation.
Xuemei WenHengyi XuPhillip R WoolleyOlivia M ConwayJun YaoAndreas MatouschekAlan M LambowitzTanya T PaullPublished in: The Journal of cell biology (2024)
Senataxin is an evolutionarily conserved RNA-DNA helicase involved in DNA repair and transcription termination that is associated with human neurodegenerative disorders. Here, we investigated whether Senataxin loss affects protein homeostasis based on previous work showing R-loop-driven accumulation of DNA damage and protein aggregates in human cells. We find that Senataxin loss results in the accumulation of insoluble proteins, including many factors known to be prone to aggregation in neurodegenerative disorders. These aggregates are located primarily in the nucleolus and are promoted by upregulation of non-coding RNAs expressed from the intergenic spacer region of ribosomal DNA. We also map sites of R-loop accumulation in human cells lacking Senataxin and find higher RNA-DNA hybrids within the ribosomal DNA, peri-centromeric regions, and other intergenic sites but not at annotated protein-coding genes. These findings indicate that Senataxin loss affects the solubility of the proteome through the regulation of transcription-dependent lesions in the nucleus and the nucleolus.
Keyphrases
- dna repair
- dna damage
- circulating tumor
- transcription factor
- cell free
- single molecule
- protein protein
- nucleic acid
- amino acid
- binding protein
- oxidative stress
- small molecule
- gene expression
- poor prognosis
- dna damage response
- genome wide
- dna methylation
- long non coding rna
- circulating tumor cells
- induced pluripotent stem cells